Paysign Slides 19% as Top Plasma Customer Moves 113 Centers to Rival
PAYS has more than doubled off its 52-week low of $3.08 on elevated volume (2.9× avg).
Summary
A large plasma-collection customer is shifting 113 donation centers to another processor by December 31, 2026, and the stock fell 19% to about $10.17 midday Tuesday. Those centers are 20% of Paysign's plasma base and would have produced roughly $10M-$11M of 2027 revenue, per DA Davidson's Peter Heckmann, who cut his 2027 and 2028 forecasts. The 10-Q filed this morning disclosed the migration; today's move is the market pricing the revenue hole. Paysign keeps the customer's remaining centers and reiterated full-year revenue guidance of $114M-$117M, so the damage lands in 2027, not 2026. The shares are still up about 97% year to date, which explains why the reaction is this sharp on a name that has run hard.
At the time of this announcement, PAYS was trading at $10.16 on NASDAQ in the Finance sector, with a market capitalization of approximately $573.7M. The 52-week trading range was $3.08 to $16.15. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.